Literature DB >> 6760858

Regulation of protein accumulation in cultured cells.

F J Ballard.   

Abstract

1. A technique is described whereby protein synthesis, protein breakdown and net protein accumulation are measured separately in monolayer cultures of mammalian cells. All rates are expressed as microgram of protein per 18 h incubation. 2. Under most incubation conditions with either L6 rat myoblasts or T47D human breast carcinoma cells the rates of protein accumulation, determined directly, agreed with the rates obtained by subtracting protein breakdown from protein synthesis. 3. Foetal calf serum, human and bovine colostrum, human milk and insulin increased protein accumulation in both cell lines, mainly as a consequence of effects on protein synthesis. 4. NH4Cl, in addition to inhibiting protein breakdown in both cell lines in the presence and in the absence of serum, stimulated protein synthesis in L6 myoblasts. 5. Leupeptin slightly inhibited protein breakdown without affecting protein-synthesis rates. 6. Cycloheximide almost completely inhibited protein synthesis, but restricted the net loss of cell proteins under most conditions because protein-breakdown rates were also decreased. 7. The assumptions, limitations and potential application of this technique for evaluating changes in protein turnover are described.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6760858      PMCID: PMC1153962          DOI: 10.1042/bj2080275

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Effect of insulin, dexamethasone, and glucagon on the amino acid transport ability of four rat hepatoma cell lines and rat hepatocytes in culture.

Authors:  D S Kelley; J E Becker; V R Potter
Journal:  Cancer Res       Date:  1978-12       Impact factor: 12.701

Review 2.  Intracellular protein degradation.

Authors:  F J Ballard
Journal:  Essays Biochem       Date:  1977       Impact factor: 8.000

3.  Effect of serum step-down on protein metabolism and proliferation kinetics of NHIK 3025 cells.

Authors:  O W Rønning; T Lindmo; E O Pettersen; P O Seglen
Journal:  J Cell Physiol       Date:  1981-04       Impact factor: 6.384

4.  Mechanisms of protein turnover in cultured fibroblasts. Differential inhibition of two lysosomal mechanisms with insulin and NH4Cl.

Authors:  J S Amenta; S C Brocher
Journal:  Exp Cell Res       Date:  1980-03       Impact factor: 3.905

5.  Differential compartmentation of leucine for oxidation and for protein synthesis in cultured skeletal muscle.

Authors:  P A Schneible; J Airhart; R B Low
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

Review 6.  Mechanisms of protein turnover in cultured cells.

Authors:  J S Amenta; S C Brocher
Journal:  Life Sci       Date:  1981-03-16       Impact factor: 5.037

7.  Leupeptin, a protease inhibitor, decreases protein degradation in normal and diseased muscles.

Authors:  P Libby; A L Goldberg
Journal:  Science       Date:  1978-02-03       Impact factor: 47.728

8.  Insulin inhibition of protein degradation in cell monolayers.

Authors:  F J Ballard; S S Wong; S E Knowles; N C Partridge; T J Martin; C M Wood; J M Gunn
Journal:  J Cell Physiol       Date:  1980-11       Impact factor: 6.384

9.  Differential effects of proteinase inhibitors and amines on the lysosomal and non-lysosomal pathways of protein degradation in isolated rat hepatocytes.

Authors:  B Grinde; P O Seglen
Journal:  Biochim Biophys Acta       Date:  1980-09-17

10.  A reexamination of the effects of creatine on muscle protein synthesis in tissue culture.

Authors:  D M Fry; M F Morales
Journal:  J Cell Biol       Date:  1980-02       Impact factor: 10.539

View more
  13 in total

1.  Protein turnover, growth and proliferation in CHO cells. Variation within and between mutant classes for salvage pathway enzymes.

Authors:  J M Gunn; M R Brancheau
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

2.  Inhibition of cell proliferation by interferons. Relative contributions of changes in protein synthesis and breakdown to growth control of human lymphoblastoid cells.

Authors:  M A McNurlan; M J Clemens
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

3.  Purification and partial sequence analysis of insulin-like growth factor-1 from bovine colostrum.

Authors:  G L Francis; L C Read; F J Ballard; C J Bagley; F M Upton; P M Gravestock; J C Wallace
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

4.  Inhibition of pyruvate carboxylase degradation and total protein breakdown by lysosomotropic agents in 3T3-L1 cells.

Authors:  C S Chandler; F J Ballard
Journal:  Biochem J       Date:  1983-03-15       Impact factor: 3.857

5.  Inhibitors of phospholipase A2 block the stimulation of protein synthesis by insulin in L6 myoblasts.

Authors:  B G Southorn; R M Palmer
Journal:  Biochem J       Date:  1990-09-15       Impact factor: 3.857

6.  A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide.

Authors:  C J Bagley; B L May; L Szabo; P J McNamara; M Ross; G L Francis; F J Ballard; J C Wallace
Journal:  Biochem J       Date:  1989-05-01       Impact factor: 3.857

7.  Inhibitors of protein synthesis also inhibit lysosomal proteolysis. Studies using cystinotic fibroblasts.

Authors:  J G Thoene; R Lemons; S Boskovich; K Borysko
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

8.  Regulation of protein synthesis and degradation in L8 myotubes. Effects of serum, insulin and insulin-like growth factors.

Authors:  E A Gulve; J F Dice
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

9.  Regulation of protein metabolism and DNA synthesis by fibroblast growth factor in BHK-21 cells.

Authors:  M Ross; F J Ballard
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

10.  Binding properties and biological potencies of insulin-like growth factors in L6 myoblasts.

Authors:  F J Ballard; L C Read; G L Francis; C J Bagley; J C Wallace
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.